Table 2 Change after medical nutrition therapy
At baseline | After MNT | P value | |
|---|---|---|---|
Overall population (n = 68) | |||
HbA1c (%) | 9.6 ± 1.8 | 7.2 ± 1.0 | < 0.001 |
(mmol/mol) | 81 ± 20 | 55 ± 11 | |
Body mass index (kg/m2) | 26.9 ± 4.1 | 25.4 ± 3.7 | < 0.001 |
Disposition index (unit) | 0.34 (0.20–0.68) | 0.88 (0.53–1.52) | < 0.001 |
Matsuda’s insulin sensitivity index (unit) | 4.70 (2.95–5.93) | 5.17 (3.48–6.89) | 0.003 |
Baseline HbA1c ≥ 9% (75 mmol/mol) (n = 39) | |||
HbA1c (%) | 10.8 ± 1.2 | 7.5 ± 1.1 | < 0.001 |
(mmol/mol) | 95 ± 14 | 58 ± 12 | |
Body mass index (kg/m2) | 26.8 ± 4.0 | 25.3 ± 3.3 | < 0.001 |
Disposition index (unit) | 0.25 (0.17–0.37) | 0.87 (0.48–1.48) | < 0.001 |
Matsuda’s insulin sensitivity index (unit) | 4.69 (3.25–5.82) | 5.35 (3.85–7.17) | 0.031 |
Baseline HbA1c < 9% (75 mmol/mol) (n = 29) | |||
HbA1c (%) | 7.9 ± 0.7 | 6.9 ± 0.7 | < 0.001 |
(mmol/mol) | 62 ± 8 | 52 ± 7 | |
Body mass index (kg/m2) | 27.0 ± 4.2 | 25.6 ± 4.1 | < 0.001 |
Disposition index (unit) | 0.62 (0.39–0.78) | 1.00 (0.69–1.51) | < 0.001 |
Matsuda’s insulin sensitivity index (unit) | 4.71 (2.42–6.18) | 4.66 (2.75–6.47) | 0.034 |